Expression of p‐JAK2 predicts clinical outcome and is a potential molecular target of acute myelogenous leukemia
Takayuki Ikezoe(Fukushima Medical University), Akihito Yokoyama(Kōchi University)
Cited by 47
Related Papers
Mitochondrial STAT3 exacerbates LPS-induced sepsis by driving CPT1a-mediated fatty acid oxidation
|Theranostics|2021|156
A novel treatment strategy targeting Aurora kinases in acute myelogenous leukemia
|Molecular Cancer Therapeutics|2007|131
Downregulation of miR‐217 correlates with resistance of ph<sup>+</sup> leukemia cells to <scp>ABL</scp> tyrosine kinase inhibitors
|Cancer Science|2013|60
Analysis of Aurora B kinase in non-Hodgkin lymphoma
|Laboratory Investigation|2009|39